Potassium chloride
As of the edition of 20 October 2026, Potassium chloride is a small molecule: marketed, first approved in 1951 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2018
- Kind
- Small molecule
- Brand name
- Lactated Ringer's In Plastic Container
- First approved
- 31 December 1951 (CA)
- Approvals on record
- 414 in 4 regions
- Holder of the most recent approval
- Genus Life Sciences; 36 holders in all
- Registered trials
- 43, 4 stopped early
- Disease areas
- Heart and blood vessels; Digestive system; Cancer; Nutrition and metabolism; Mental health; Eye
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 9 | 3 | 1 | 1 |
| Phase 1 | 2 | 2 | 0 | 0 |
| Phase 2 | 8 | 5 | 1 | 2 |
| Phase 3 | 7 | 4 | 2 | 0 |
| Phase 4 | 17 | 13 | 2 | 1 |
| All trials | 43 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Pfizer | Applicant and Later holder | 1951 to now |
| Baxter Healthcare | Later holder | 1957 to now |
| B. Braun Medical | Applicant | 1974 to now |
| Alcon | Later holder | 1980 to now |
| Upsher-Smith | Later holder | 1986 to now |
| Merck & Co. | Later holder | 1986 to now |
| Johnson & Johnson | Later holder | 1994 to now |
| Bristol Myers Squibb | Acquired holder | 2003 to now |
| Kv Pharmaceutical | Acquired holder | 2003 to now |
| Savage | Acquired holder | 2003 to now |
| Nesher Pharmaceuticals | Acquired holder | 2011 to now |
| AbbVie | Acquired holder | 2012 to now |
| Abbott | Later holder | 2013 to now |
| Genus Life Sciences | Acquired holder | 2017 to now |
| EA Pharma | Applicant | 2018 to now |
| Genus Lifesciences | Acquired holder | 2024 to now |
| Otsuka | Acquired holder | 2025 to now |
| Eli Lilly | Applicant | |
| Novartis | Later holder |